Please login to the form below

Not currently logged in
Email:
Password:

antibiotics

This page shows the latest antibiotics news and features for those working in and with pharma, biotech and healthcare.

Nature's way

Nature's way

Led by headlines and public opinion, they are not good at, for example, demoting an ultra-rare disease or incremental oncology gain to a lower priority than, say, new antibiotics or

Latest news

More from news
Approximately 66 fully matching, plus 303 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 6 fully matching, plus 43 partially matching documents found.

Latest appointments

  • Henry Skinner has been appointed as the first CEO of the AMR Action Fund Henry Skinner has been appointed as the first CEO of the AMR Action Fund

    Skinner also worked as the chief executive officer of the small, antibiotic-focused biotech SelectX Pharmaceuticals and president and chief executive officer at NeoGenesis Pharmaceuticals. ... The AMR Action Fund is an initiative created to bring two to

  • New faces at 90TEN, Lucid Group and Porterhouse New faces at 90TEN, Lucid Group and Porterhouse

    In that role, Cook delivered initiatives to improve national health, including promoting responsible antibiotic use, protecting against STIs and encouraging rates of childhood immunisation.

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Francesco Maria Lavino joins to support commercialisation of its new antibiotic. ... He said: “Nabriva Therapeutics is poised to introduce what is potentially the first new class of antibiotics for systemic human use in nearly two decades.

  • Destiny Pharma appoints new CEO Destiny Pharma appoints new CEO

    development. He said: “The resistance to antibiotics is becoming a global issue that needs to be addressed and I believe Destiny has a significant part to play.

  • Dr Engelbert Tjeenk Willink joins Allecra Therapeutics Dr Engelbert Tjeenk Willink joins Allecra Therapeutics

    Regulatory authorities have recognised the potential that Allecra’s novel antibiotic may contribute towards solving the crisis of resistant bacterial infections, and out lead development programme has been significantly expedited. ... With these new

More from appointments
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 30 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...